Testing for Past Exposure to Histoplasmosis

Primary Testing Method: Histoplasma Serology

The American Thoracic Society recommends Histoplasma antibody testing as the preferred method for detecting past exposure in immunocompetent individuals, with sensitivity ranging from 80-95% in patients with pulmonary histoplasmosis 1, 3, 4
The test has excellent specificity, making it reliable for confirming prior exposure, with less than 5% false-positive rate in endemic area residents 1, 2, 4

For immunocompetent patients, the sensitivity of Histoplasma antibody testing is 80-95% for pulmonary histoplasmosis 1, 3
The specificity of the test is excellent, with less than 5% false-positive rate in endemic area residents 1, 2, 4

The Infectious Diseases Society of America notes that the utility of serologic testing is dramatically reduced in immunocompromised patients, with only 18% sensitivity in organ transplant recipients and 45% sensitivity in HIV/AIDS patients 1, 3

The yield of Histoplasma serology depends critically on timing in relation to infection, with antibodies taking weeks to develop after initial exposure 1, 3

The Centers for Disease Control and Prevention recommends that Histoplasma antigen testing (urine or serum) is designed for active/acute infection, not past exposure, with 95% sensitivity in urine and 85% in serum for disseminated disease but is insensitive for remote or resolved infections 5, 6

For immunocompetent patients seeking evidence of past exposure, the American College of Chest Physicians recommends ordering Histoplasma serology (antibody testing) and interpreting positive results as evidence of past or current infection 1

Cross-reactivity occurs with other endemic mycoses, including blastomycosis, coccidioidomycosis, paracoccidioidomycosis, and talaromycosis, which can complicate interpretation, and clinical correlation with exposure history and geographic location is essential 1, 2, 4
Background seropositivity in endemic areas means that positive serology indicates exposure but does not necessarily indicate active disease requiring treatment, with high baseline seropositivity rates in the Ohio and Mississippi River valleys 1, 6